HB164 (2005) Detail

Relative to the use of chelating agents or chelation drug therapy for the treatment of medical conditions.


HB 164 – AS INTRODUCED

2005 SESSION

05-0122

01/09

HOUSE BILL 164

AN ACT relative to the use of chelating agents or chelation drug therapy for the treatment of medical conditions.

SPONSORS: Rep. Slocum, Hills 6

COMMITTEE: Health, Human Services and Elderly Affairs

ANALYSIS

This bill authorizes licensed physicians to prescribe a chelating agent or chelation drug therapy for medical conditions.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

05-0122

01/09

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Five

AN ACT relative to the use of chelating agents or chelation drug therapy for the treatment of medical conditions.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 New Section; Chelation Drug Therapy. Amend RSA 329 by inserting after section 31 the following new section:

329:32 Chelation Drug Therapy.

I. A licensed physician may prescribe, dispense, administer, supply, sell, give, or otherwise make available to any person, any chelating agent or chelation therapy for the treatment or prevention of any medical condition when the physician, in his or her professional judgment, deems it in the best interest of a patient.

II. No physician shall be subject to disciplinary action by the board of medicine for prescribing or administering chelation therapy to a patient under his or her care who has requested the substance. A hospital or health facility shall not be liable for any damages resulting from the introduction of chelation therapy by a physician onto the premises contrary to any regulation of the hospital or health facility.

III. For the purposes of this section, “chelating agent” means any medication which is a parenteral or oral metal-binding and bioinorganic agent. For the purposes of this section, “chelation therapy” means a therapy to restore cellular homeostasis through the use of a parenteral or oral chelating agent.

IV. All proposed rules on the subject of chelation therapy previously published as a notice of intent and any and all rules adopted by the board of medicine in conflict with the provisions of this section are hereby rescinded.

2 Effective Date. This act shall take effect 60 days after its passage.

Links

HB164 at GenCourtMobile

Action Dates

Date Body Type

Bill Text Revisions

HB164 Revision: 8652 Date: Jan. 21, 2010, midnight

Docket